- In March 2024, Thermo Fisher Scientific launched the Gibco Countess Automated Cell Counter, a new instrument designed to simplify and accelerate cell counting for bioburden testing and other applications. This innovative cell counter offers improved accuracy, reproducibility, and data management capabilities, enhancing efficiency in quality control laboratories.
- In February 2024, Merck KGaA introduced a new line of MilliporeSigma rapid microbiological testing solutions, enabling faster detection of microbial contamination in pharmaceutical and food samples. These rapid testing kits are designed to reduce turnaround times and improve workflow efficiency, supporting quicker release of products and minimizing production delays.
- In January 2024, bioMérieux announced a partnership with an automation solutions provider to integrate its bioburden testing assays with robotic platforms. This collaboration aims to develop fully automated workflows for bioburden testing, reducing manual handling and improving data integrity in high-throughput laboratories.
- In December 2023, Becton, Dickinson and Company (BD) received FDA clearance for its new rapid microbial detection system, intended for use in pharmaceutical manufacturing. This system provides real-time detection of microbial contamination, allowing for immediate corrective actions and minimizing the risk of product recalls.
- In November 2023, Sartorius AG expanded its portfolio of membrane filtration products with the launch of a new range of filters specifically designed for bioburden testing of viscous solutions. These new filters offer improved flow rates and reduced clogging, enhancing the efficiency of bioburden testing in the pharmaceutical and food and beverage industries
